0.4618
Salarius Pharmaceuticals Inc Aktie (SLRX) Neueste Nachrichten
Will Salarius Pharmaceuticals Inc. see short term momentumEarnings Summary Report & Stepwise Trade Signal Implementation - Newser
Using RSI to spot recovery in Salarius Pharmaceuticals Inc.Weekly Stock Recap & Reliable Intraday Trade Alerts - Newser
What analysts say about Salarius Pharmaceuticals Inc. stock outlookQuarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
Salarius Pharmaceuticals Inc. stock prediction for this weekPortfolio Update Report & Weekly Breakout Opportunity Watchlist - Newser
Visualizing Salarius Pharmaceuticals Inc. stock with heatmapsEarnings Miss & Weekly High Conviction Trade Ideas - Newser
What MACD and RSI say about Salarius Pharmaceuticals Inc.Weekly Loss Report & Weekly Watchlist of Top Performers - Newser
What’s next for Salarius Pharmaceuticals Inc. stock priceTrade Ideas & Weekly Breakout Opportunity Watchlist - Newser
Is a relief rally coming for Salarius Pharmaceuticals Inc. holdersQuarterly Portfolio Summary & Long-Term Safe Investment Plans - Newser
Why Salarius Pharmaceuticals Inc. is moving today2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser
Advanced analytics toolkit walkthrough for Salarius Pharmaceuticals Inc.Weekly Trading Summary & Weekly Stock Breakout Alerts - Newser
Technical signs of recovery in Salarius Pharmaceuticals Inc.Market Performance Report & Reliable Breakout Forecasts - Newser
Using data filters to optimize entry into Salarius Pharmaceuticals Inc.Trade Exit Report & Safe Capital Growth Plans - Newser
What recovery options are there for Salarius Pharmaceuticals Inc.July 2025 EndofMonth & Weekly Momentum Stock Picks - Newser
Salarius Pharmaceuticals' $50M Shelf Filing: A Strategic Move to Fuel High-Unmet-Need Cancer Therapies - AInvest
Published on: 2025-08-16 06:53:45 - Newser
Can you recover from losses in Salarius Pharmaceuticals Inc.2025 Volatility Report & Real-Time Market Trend Scan - Newser
Salarius Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:SLRX - Benzinga
Using Bollinger Bands to evaluate Salarius Pharmaceuticals Inc.Trade Ideas & Low Risk Investment Opportunities - Newser
Regression Model Predicts Rangebound Movement in Salarius Pharmaceuticals Inc.2025 Geopolitical Influence & Growth Oriented Trade Recommendations - sundaytimes.kr
Will Salarius Pharmaceuticals Inc. bounce back from current support2025 Year in Review & Expert Verified Movement Alerts - Newser
Salarius Pharmaceuticals To Carry Out 1-for-15 Reverse Stock Split On August 18th, 2025 - 富途牛牛
What’s next for Salarius Pharmaceuticals Inc. stockJuly 2025 Weekly Recap & AI Forecast Swing Trade Picks - sundaytimes.kr
Heatmap analysis for Salarius Pharmaceuticals Inc. and competitorsJuly 2025 Action & Risk Managed Trade Strategies - Newser
Salarius Pharmaceuticals Announces Reverse Stock Split - msn.com
Signal strength of Salarius Pharmaceuticals Inc. stock in tech scannersJuly 2025 Drop Watch & Daily Stock Trend Reports - Newser
How Efficient Is Salarius Pharmaceuticals Inc. at Controlling Operating CostsTrade Exit Summary & Reliable Price Breakout Alerts - Newser
How Salarius Pharmaceuticals Inc. stock performs during market volatilityMarket Performance Report & Free Real-Time Volume Trigger Notifications - Newser
Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split - citybiz
Salarius Pharmaceuticals To Implement 1-for-15 Reverse Stock Split - Nasdaq
Salarius Pharmaceuticals to implement 1-for-15 reverse stock split By Investing.com - Investing.com Australia
Salarius Pharmaceuticals to implement 1-for-15 reverse stock split - Investing.com
Salarius Pharmaceuticals announces 1-for-15 reverse stock split - MarketScreener
Salarius Pharmaceuticals Announces 1-For-15 Reverse Stock Split - TradingView
Cancer Drug Developer Salarius Launches Stock Consolidation to Meet Nasdaq Requirements - Stock Titan
Salarius Pharmaceuticals Q2 2023 Earnings Report | Financial OutlookNews and Statistics - IndexBox
Salarius: Q2 Earnings Snapshot - New Haven Register
What’s next for Salarius Pharmaceuticals Inc. stock price [2025 Valuation Update]Stock Portfolio Risk Control - Newser
Market reaction to Salarius Pharmaceuticals Inc.’s recent news [Forecast Cut]Free Stepwise Trade Signal Implementation - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):